CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 126 filers reported holding CYTOKINETICS INC in Q4 2015. The put-call ratio across all filers is 0.85 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $1,632,000 | +31.8% | 134,303 | -0.4% | 0.00% | 0.0% |
| Q3 2016 | $1,238,000 | +0.8% | 134,826 | +4.2% | 0.00% | 0.0% |
| Q2 2016 | $1,228,000 | +36.1% | 129,386 | +1.1% | 0.00% | +100.0% |
| Q1 2016 | $902,000 | -32.1% | 127,988 | +0.7% | 0.00% | -50.0% |
| Q4 2015 | $1,329,000 | +57.8% | 127,055 | +0.9% | 0.00% | +100.0% |
| Q3 2015 | $842,000 | -3.2% | 125,895 | -2.8% | 0.00% | 0.0% |
| Q2 2015 | $870,000 | +12.1% | 129,536 | +13.2% | 0.00% | 0.0% |
| Q1 2015 | $776,000 | -15.9% | 114,474 | -0.6% | 0.00% | 0.0% |
| Q4 2014 | $923,000 | +124.0% | 115,217 | -1.6% | 0.00% | 0.0% |
| Q3 2014 | $412,000 | -24.0% | 117,069 | +3.2% | 0.00% | 0.0% |
| Q2 2014 | $542,000 | -38.9% | 113,429 | +21.4% | 0.00% | 0.0% |
| Q1 2014 | $887,000 | +77.8% | 93,408 | +21.7% | 0.00% | 0.0% |
| Q4 2013 | $499,000 | -15.4% | 76,766 | -1.5% | 0.00% | 0.0% |
| Q3 2013 | $590,000 | – | 77,970 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 4,989,218 | $47,348,000 | 10.09% |
| EcoR1 Capital, LLC | 2,139,697 | $20,306,000 | 8.01% |
| Healthcare Value Capital, LLC | 100,000 | $949,000 | 1.15% |
| DAFNA Capital Management LLC | 150,000 | $1,424,000 | 1.13% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 151,106 | $1,434,000 | 1.07% |
| Avoro Capital Advisors LLC | 503,900 | $4,782,000 | 1.06% |
| ACUTA CAPITAL PARTNERS, LLC | 140,969 | $1,338,000 | 0.64% |
| Iguana Healthcare Management, LLC | 150,000 | $1,424,000 | 0.58% |
| WASATCH ADVISORS LP | 1,746,096 | $16,570,000 | 0.25% |
| Virtus ETF Advisers LLC | 29,379 | $279,000 | 0.21% |